Pfizer said on Thursday that it has formally submitted an application to the U.S. Food and Drug Administration (FDA) for approval of its new crown vaccine in cooperation with BioNTech for children aged 5 to 11.
As soon as the news came out, parents who desperately wanted their children to have the opportunity to be vaccinated were relieved. Because the new school year has begun, the Delta virus is still sweeping across the United States, causing a surge in the number of hospitalizations in the United States, including those young children, who have no chance of being connected to a vaccine.
Last month, according to data released by Pfizer, the vaccine is safe in children aged 5 to 11. The tested vaccine dose was only a two-dose regimen of 10 micrograms, while the dose used for adolescents and adults was 30 micrograms. According to data collected in a trial involving more than 2,000 children, it showed a “strong” antibody response, and the children appeared to have fewer side effects of fever and chills.
To avoid confusion, Pfizer’s 1/3 concentration children’s vaccine bottle is labeled “Pediatric Use”, which is easy to distinguish on the outside.
If authorized by the health regulatory agency, children between the ages of 5 and 11 may begin to receive vaccination in November, and schools are predicted to become the main vaccination sites. Previously, the adult population was vaccinated through nursing homes or mass vaccination sites. Adolescents between the ages of 12 and 15 are vaccinated in pharmacies and doctor’s offices.
Virginia Governor Ralph Northam said at the COVID-19 press conference last week, “The easiest and fairest way to administer the vaccine is to set it up in a school and be carried out by health department personnel. Therefore, our team is working with schools. Work together to make this plan a reality as much as possible.”
According to a survey published by the Kaiser Family Foundation in September, about one-third of parents of children aged 5 to 11 will observe the performance of the vaccine before making a decision. And about a quarter of parents said they would not vaccinate their children. Approximately 34% of parents of children aged 5 to 11 will vaccinate their children immediately after the vaccine is approved.
In August of this year, the Pfizer vaccine was fully approved by the FDA for people aged 16 and above, but for children 12 to 15 years old, it is still under “emergency use authorization.” In the United States, Pfizer vaccine is still the only vaccine authorized for use in 12-year-old children. Pfizer said that the results of the study on children under the age of 6 months to 5 years old may come out in the fourth quarter of this year.
According to federal data, as of September 25, there are 202.9 new crown cases per 100,000 people in the United States every week for children aged 5-11 years, which is the week with the highest infection rate for this group of people. For adolescents aged 12-15 and adolescents aged 16-17, the infection rates were 211 and 219.5 new crown cases per 100,000 people, respectively.
This article is from Wall Street’s knowledge, welcome to download the APP to see moreReturn to Sohu to see more
Editor:
Disclaimer: The opinions of this article only represent the author himself. Sohu is an information publishing platform. Sohu only provides information storage space services.
.